Amount Raised
$117 Million
Round Type
Post-IPO Equity
BostonBiotechnologyHealthcareInvestors
Description
On November 11, 2026, PepGen Inc. entered into an Underwriting Agreement to offer 25 million shares of its common stock at a public price of $5.00 per share. The offering is expected to net approximately $116.9 million, which will contribute to the ongoing clinical development of its product candidate and support working capital. The offering may close on or about November 13, 2026, pending customary conditions.
Quick answer
PepGen raised $117 Million in a Post-IPO Equity round, dated November 12, 2026. Investors: Guggenheim Securities, LLC, Stifel, Nicolaus & Company, Incorporated and Leerink Partners LLC. PepGen is based in Boston, Massachusetts, United States.
- How much did PepGen raise?
- PepGen raised $117 Million in a Post-IPO Equity round on November 12, 2026.
- Who invested in PepGen?
- Guggenheim Securities, LLC, Stifel, Nicolaus & Company, Incorporated and Leerink Partners LLC are named as investors in this round.
- What does PepGen do?
- PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases.
- Where is PepGen based and how big is it?
- PepGen is based in Boston, Massachusetts, United States. Fundz records about 84 employees.
- Who are the decision-makers at PepGen?
- Fundz holds 3 contacts at PepGen. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as PepGen that raised within 45 days of this round, from Fundz verified event records.
- Equinox raised $1B on November 2, 2026.
- Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
- Araceli Biosciences raised $4.5M (Seed) on October 20, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- X4 Pharmaceuticals raised $150M (Debt Financing) on October 12, 2026.
Who to call at PepGen, and when
A new round usually means PepGen is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PepGen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PepGen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PepGen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PepGen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
PepGen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.